News

Some stock-trading platforms enable their users to automatically replicate the positions taken by experienced investors or other famous figures. Many investors might prefer to do their own research

Medtronic (NYSE: MDT) is a medical device company with vast and diverse operations. Its business is fairly stable although the stock's returns haven't been all that great. However, it also provides

UnitedHealth (NYSE: UNH) is struggling to recover investor trust that was eroded when the company missed its earnings expectations.

*Stock prices used were the afternoon prices of June 2, 2025. The

Investors are always looking for smart money managers to get ideas from. One investor I like to follow is David Tepper, the billionaire founder of Appaloosa Management. And, fortunately, I can get

UnitedHealth Group (NYSE: UNH) stock has been in a free fall due to a flurry of bad news. Heading into trading this week, shares of the health insurer had crashed more than 40% thus far in 2025

Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Should you chase high yields from slow-growing businesses or invest in lower-yield providers with more

Although fundamental investing wisdom tells us to "buy low," it may still be worthwhile to purchase shares of top companies following significant runs. Any point can be considered low -- even after

HealthEquity (NASDAQ:HQY) reported fiscal 2026 first quarter (ended April 30, 2025) earnings on June 3, 2025, delivering 15% year-over-year revenue growth and raising full-year guidance. Key

Cathie Wood is rolling again. Growth stocks are back in favor, and that's good news for the founder, CEO, and primary investment manager of the Ark Invest family of exchange-traded funds (ETFs).

U.S. Rep. Marjorie Taylor Greene, a Georgia Republican, recently disclosed some buys in red-hot artificial intelligence (AI) stock Palantir Technologies (NASDAQ: PLTR), according to data compiled by

It took 13 years, 15 nations, and roughly $100 billion to build the International Space Station (ISS). But one company thinks it can build a replacement for as little as $3 billion -- or less.

That

On a generally upbeat Monday for the stock market, investors weren't only buying into U.S. companies. Quite a few of them also piled into the American Depositary Receipts (ADRs) of Danish biotech Ge

BioNTech (NASDAQ: BNTX), one of the companies made famous for its role developing vaccines with Pfizer (NYSE: PFE) during the COVID-19 pandemic, soared 20.2% through 12:50 p.m. Monday on news

Even though broader equities have been highly volatile this year, it's still a good idea to invest in stocks for a straightforward reason. Holding shares of top companies for five years and beyond

A new month has arrived. Investors now have a fresh opportunity to buy great stocks. Three Motley Fool contributors believe they've found no-brainer healthcare stocks to buy in June. Here's why they

The obesity treatment market is booming, with groundbreaking drugs like Eli Lilly's (NYSE: LLY) Zepbound delivering transformative patient results and powering its stock to a spectacular 400% return

Shares of Summit Therapeutics (NASDAQ: SMMT) tanked more than 30% on Friday, May 30. Such dramatic price swings aren't unusual in the biotechnology industry; in this case, disappointing data from an

The past three years have been challenging for Pfizer (NYSE: PFE). Revenue and earnings have moved in the wrong direction, as has the company's share price. The stock is down by 56% since 2022

More than 100 million Americans use AT&T's (NYSE: T) products and services. So do nearly 2.5 million businesses. How many investors rely on A&T's stock to generate reliable dividend income? I don't